KLOW: The Complete Guide to This Four-Peptide Blend
KLOW is not a single molecule; it's a mixture of four peptides combined in a single 80 mg vial. Each component has its own studies, but the mixture itself has never been tested. Here's what it contains, what we know, what we don't know, and how much it costs.
What is KLOW?
KLOW is a fixed mixture of GHK-Cu, BPC-157, TB-500, and KPV, sold as a lyophilized powder. Its name comes from an older mixture, GLOW, which combined the first three peptides: the "K" refers to the KPV added to the formula. This name is a marketing term. It does not designate a drug or a standard, and the composition can therefore vary from one brand to another.
- Just one vial : the four peptides are lyophilized together and can no longer be separated.
- A fixed ratio : GHK-Cu represents the largest part of the vial, i.e. 50 mg out of 80 mg.
- A research reagent : no country has authorized it as a medicine.
Composition of KLOW 80 mg
| Peptide | Quantity advertised | Measured by Janoshik | Nature |
|---|---|---|---|
| GHK-Cu | 50 mg | 63.49 mg | Tripeptide bound to a copper ion |
| BPC-157 | 10 mg | 11.15 mg | Synthetic peptide of 15 amino acids |
| TB-500 | 10 mg | 11.36 mg | Beta-4 thymosin-related peptide |
| KPV | 10 mg | 11.33 mg | Tripeptide derived from alpha-MSH |
Always compare quantities: some sellers use the name KLOW for a 55 mg vial or for a different ratio. Details of our batch are on the page KLOW COA.
The role of each peptide
The idea behind the mixture is to combine four lines of research on tissue repair. This logic remains a hypothesis: no study has shown that the four peptides work better together than separately.
- GHK-Cu: studied for its action on collagen and skin renewal. See our GHK-Cu guide.
- BPC-157 : studied mainly in rats, on tendons, muscles and digestive mucosa.
- TB-500 : studied for cell migration to an injured area, through its link with actin.
- KPV : studied for its effect on inflammation, particularly in mouse models of colitis.
What is proven, and what is not
The essential point can be summed up in one sentence: No trials have been published on the KLOW mixture.The benefits advertised online are derived from studies on each component, and these studies are mostly preclinical. In humans, BPC-157 has only three small studies without a control group. Details, peptide by peptide, can be found on the page benefits of KLOWand tolerance on the page side effects.
KLOW Status
KLOW is not authorized as a drug in either Europe or the United States. In France, the ANSM (National Agency for Medicines and Health Products Safety) issued a warning in July 2026 against peptides sold online, and the Île-de-France pharmacovigilance center cites BPC-157, GHK-Cu, and TB-500 among the products that have been reported. In the United States, an FDA advisory committee voted in July 2026 in favor of BPC-157, KPV, and TB-500 for compounded preparations, by a vote of 8 to 6. This opinion is not binding and does not constitute authorization. BPC-157 and TB-500 are prohibited by the World Anti-Doping Agency.
KLOW price in France
On November 4, 2026, we recorded the prices displayed on Google.fr for an 80 mg vial, excluding shipping costs and welcome discounts.
| Seller | Price of the 80 mg vial | Price per mg |
|---|---|---|
| MyPeptide | €89.90 | €1.12/mg |
| Five other sellers in euros | from €95 to €174.90 | from €1.19 to €2.19/mg |
Price is no indicator of quality. Before comparing two vials, verify that the proportions are the same and that the seller publishes a batch report with a verification key. Bacteriostatic water is used for reconstitution.
One lyophilized vial, i.e., €1.12/mg. Batch MP-777K801 quantified by Janoshik: 97.33 mg measured, 80 mg stated. Shipping from the European Union in 2 to 5 business days; delivery €10, free from €160.
KLOW 80 mg – €89.90
- Benefits: what studies say
- KLOW, GLOW or Wolverine
- Side effects and risks
- Our Janoshik (COA) analysis
- The mechanisms of KLOW (article)
- KPV, one of the four peptides
Frequently asked questions
What is KLOW?
A mixture of four peptides in a single vial: GHK-Cu, BPC-157, TB-500, and KPV. The standard size contains 80 mg, including 50 mg of GHK-Cu. This is a research reagent, not a drug.
What does KLOW mean?
The name derives from GLOW, a mixture of GHK-Cu, BPC-157, and TB-500. The K refers to the KPV added to this formula. This name does not correspond to any official standard.
What dosage for KLOW?
No dosage has been validated: the mixture has not been tested. MyPeptide provides neither dosage nor protocol. Our products are intended exclusively for scientific laboratory research.
What is the price of KLOW?
At MyPeptide, the 80mg vial costs €89.90, or €1.12/mg. On November 4, 2026, five other sellers in euros were advertising prices from €95 to €174.90, excluding shipping and welcome discounts.
Is KLOW authorized as a medicine in France?
No. No country has authorized it as a medicine. The ANSM (French National Agency for Medicines and Health Products Safety) issued a warning against peptides sold online in July 2026.
Sources: Janoshik report #223511; Île-de-France pharmacovigilance center, alert dated July 23, 2026; AJMC, July 31, 2026 (FDA committee vote); USADA (WADA Prohibited List). MyPeptide products are intended exclusively for scientific laboratory research.
